Sanofi Collaboration Drives Lexicon Pharma's (LXRX) 4Q Success; Wedbush Raises Price Target to $28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.42 -0.06 (4.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.48 | 52 Week High | $19.62 | |||
| Open | $1.47 | 52 Week Low | $7.65 | |||
| Day High | $1.50 | P/E | N/A | |||
| Day Low | $1.38 | EPS | $-0.22 | |||
| Volume | 2,444,205 | |||||
